Colonic ulceration in a patient with renal disease and hyperkalemia
Authors:
- Robert A. SableRSRobert A. Sable
- Kenneth FriedmanKFKenneth Friedman
- 1 October 2012
- journal article
- case report
- Published by Wolters Kluwer Health in JAAPA
- Vol. 25 (10) , 34-8
Abstract
A drug commonly used to treat hyperkalemia has the potential to damage the GI mucosa, especially in surgical patients or patients with end-stage renal disease.Keywords
This publication has 7 references indexed in Scilit:
- Intestinal Necrosis due to Sodium Polystyrene Sulfonate (Kayexalate) in SorbitolSouthern Medical Journal, 2009
- Pseudohyperkalemia in serum: the phenomenon and its clinical magnitudeJournal of Laboratory and Clinical Medicine, 2006
- Upper Gastrointestinal Tract Injury in Patients Receiving Kayexalate (Sodium Polystyrene Sulfonate) in SorbitolAmerican Journal of Surgical Pathology, 2001
- Combined gastric and ileocecal toxicity (serpiginous ulcers) after oral kayexalate in sorbital therapyAmerican Journal of Kidney Diseases, 1997
- Necrosis of the Gastrointestinal Tract in Uremic Patients as a Result of Sodium Polystyrene Sulfonate (Kayexalate) in SorbitolAmerican Journal of Surgical Pathology, 1997
- Intestinal Necrosis Associated With Postoperative Orally Administered Sodium Polystyrene Sulfonate in SorbitolAmerican Journal of Kidney Diseases, 1992
- Management of Hyperkalemia with a Cation-Exchange ResinNew England Journal of Medicine, 1961